INCATE has selected Arvalus as a promising startup to tackle antimicrobial resistance

We were able to successfully secure the first stage of INCATE funding after our presentation to the selection committee. We are looking forward to the opportunities that arise from this and are also trying to take the next steps in the INCATE program. With the INCATE funding, we want to specifically address the challenges of LBPs and their production in order to achieve our next milestones.

Read more about the Incate program here.